Keren Mizrahi

Keren Mizrahi is a Senior Scientist at Brainstorm Cell Therapeutics since May 2019, leading the development of automated bioreactor-based processes for an autologous stem cell therapy product, and designing validation studies for cell-based methods. Previously, Keren served as a Research Associate at the Bar Ilan Institute for Nanotechnology and Advanced Materials, focusing on CRISPR genome editing technology for genetic disorders in hematopoietic stem cells, and as a Development and Manufacturing Associate at Cognate BioServices Israel, where Keren improved the purity and efficiency of cellular therapies. Keren's early career included roles as a Research Assistant and Assistant Teacher at Bar Ilan University, specializing in molecular biology. Keren holds a Ph.D. in Medical Science from Tel Aviv University, an M.Sc. in Biotechnology, and a B.Sc. in Life Sciences from Bar Ilan University.